{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:30:09Z","timestamp":1794547809669,"version":"4.9.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Thinness (low percentage of body fat, low body mass index [BMI], or low body weight) was evaluated as a risk factor for low bone mineral density (BMD) or increased bone loss in a randomized trial of alendronate for prevention of osteoporosis in recently postmenopausal women with normal bone mass (n = 1609). The 2-year data from the placebo group were used (n = 417). Percentage of body fat, BMI, and body weight were correlated with baseline BMD (r = \u22120.13 to \u22120.43, p &amp;lt; 0.01) and 2-year bone loss (r = \u22120.14 to \u22120.19, p &amp;lt; 0.01). Women in the lowest tertiles of percentage of body fat or BMI had up to 12% lower BMD at baseline and a more than 2-fold higher 2-year bone loss as compared with women in the highest tertiles (p \u2264 0.004). Women with a lower percentage of body fat or BMI had higher baseline levels of urine N-telopeptide cross-links (r = \u22120.24 to \u22120.31, p &amp;lt; 0.0001) and serum osteocalcin (r = \u22120.12 to \u22120.15, p &amp;lt; 0.01). To determine if the magnitude of treatment effect of alendronate was dependent on these risk factors, the group treated with 5 mg of alendronate was included (n = 403). There were no associations between fat mass parameters and response to alendronate treatment, which indicated that risk of low bone mass and increased bone loss caused by thinness could be compensated by alendronate treatment. In conclusion, thinness is an important risk factor for low bone mass and increased bone loss in postmenopausal women. Because the response to alendronate treatment is independent of fat mass parameters, prevention of postmenopausal osteoporosis can be equally achieved in thinner and heavier women.<\/jats:p>","DOI":"10.1359\/jbmr.1999.14.9.1622","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T01:34:54Z","timestamp":1146101694000},"page":"1622-1627","source":"Crossref","is-referenced-by-count":347,"title":["Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women"],"prefix":"10.1093","volume":"14","author":[{"given":"P.","family":"Ravn","sequence":"first","affiliation":[{"name":"Center for Clinical and Basic Research, Ballerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cizza","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Rahway, New Jersey, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H.","family":"Bjarnason","sequence":"additional","affiliation":[{"name":"Center for Clinical and Basic Research, Ballerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Rahway, New Jersey, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Daley","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Rahway, New Jersey, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"Wasnich","sequence":"additional","affiliation":[{"name":"Hawaii Osteoporosis Center, Honolulu, Hawaii, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mcclung","sequence":"additional","affiliation":[{"name":"Oregon Osteoporosis Center, Portland, Oregon, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hosking","sequence":"additional","affiliation":[{"name":"Division of Mineral Metabolism, City Hospital, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Yates","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories, Rahway, New Jersey, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Center for Clinical and Basic Research, Ballerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020713355464400_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01623352","article-title":"Symptomatic fracture incidence in elderly men and women: Dubbo Osteoporosis Epidemiol Study (DOES)","volume":"4","author":"Jones","year":"1994","journal-title":"Osteoporos Int"},{"key":"2024020713355464400_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01623271","article-title":"Prevalence and incidence of vertebral deformities","volume":"3","author":"Melton","year":"1993","journal-title":"Osteoporos Int"},{"key":"2024020713355464400_bib3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJM199208273270908","article-title":"The prevention and treatment of osteoporosis","volume":"327","author":"Riggs","year":"1992","journal-title":"N Engl J Med"},{"key":"2024020713355464400_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00003086-199003000-00024","article-title":"The future of hip fractures in the United States: Numbers, costs, and potential effect of postmenopausal estrogen","volume":"252","author":"Cummings","year":"1990","journal-title":"Clin Orthop"},{"key":"2024020713355464400_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.298.6678.924","article-title":"Determinants of bone density in normal women: Risk factors for future osteoporosis?","volume":"298","author":"Stevenson","year":"1989","journal-title":"Br Med J"},{"key":"2024020713355464400_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02556691","article-title":"Bone density of the radius, spine, and hip in relation to percent of ideal body weight in postmenopausal women","volume":"40","author":"Dawson-Hughes","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"2024020713355464400_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jbmr.5650070109","article-title":"Bone mass and body composition in normal women","volume":"7","author":"Lindsay","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020713355464400_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/8756-3282(87)90062-7","article-title":"Obesity and postmenopausal bone loss: The influence of obesity on vertebral density and bone turnover in postmenopausal women","volume":"8","author":"Ribot","year":"1988","journal-title":"Bone"},{"key":"2024020713355464400_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/oxfordjournals.aje.a116842","article-title":"Relation between body size and bone mineral density in elderly men and women","volume":"138","author":"Edelstein","year":"1993","journal-title":"Am J Epidemiol"},{"key":"2024020713355464400_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/8756-3282(89)90072-0","article-title":"Influence of soft tissue body composition on bone mass and metabolism","volume":"10","author":"Hassager","year":"1989","journal-title":"Bone"},{"key":"2024020713355464400_bib11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(87)91671-0","article-title":"Prediction of rapid bone loss in postmenopausal women","volume":"1","author":"Christiansen","year":"1987","journal-title":"Lancet"},{"key":"2024020713355464400_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199802193380801","article-title":"Prevention of bone loss with alendronate in postmenopausal women under 60 years of age","volume":"338","author":"Hosking","year":"1998","journal-title":"N Engl J Med"},{"key":"2024020713355464400_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0022-2143(97)90075-5","article-title":"Serum osteocalcin and bone mineral density at various skeletal sites: A study performed with three different assays","volume":"129","author":"Minisola","year":"1997","journal-title":"J Lab Clin Med"},{"key":"2024020713355464400_bib14","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone resorption: Quantitation of type 1 collagen cross-linked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020713355464400_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF01623390","article-title":"Comparison of bone densitometry of the phalanges, distal forearm and axial skeleton in early postmenopausal women participating in the EPIC study","volume":"6","author":"Ravn","year":"1996","journal-title":"Osteoporos Int"},{"key":"2024020713355464400_bib16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024020713355464400_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.303.6808.961","article-title":"Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study","volume":"303","author":"Hansen","year":"1991","journal-title":"BMJ"},{"key":"2024020713355464400_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","article-title":"Bisphosphonates: Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease","volume":"42","author":"Fleisch","year":"1991","journal-title":"Drugs"},{"key":"2024020713355464400_bib19","first-page":"926","article-title":"Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals","volume":"19","author":"Lin","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"2024020713355464400_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0009-9236(95)90245-7","article-title":"Studies of oral bioavailablity of alendronate","volume":"58","author":"Gertz","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"2024020713355464400_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jbmr.5650020605","article-title":"Total bone calcium in normal women: Effect of age and menopause status","volume":"2","author":"Gallagher","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024020713355464400_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jbmr.5650020205","article-title":"Computer modelling and analysis of cross-sectional bone density studies with respect to age and the menopause","volume":"2","author":"Sambrook","year":"1987","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.1999.14.9.1622","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/9\/1622\/56600207\/5650140918.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/9\/1622\/56600207\/5650140918.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:59:00Z","timestamp":1710341940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/14\/9\/1622-1627\/7514941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9,1]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[1999,9,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.1999.14.9.1622","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,9,1]]},"published":{"date-parts":[[1999,9,1]]}}}